SMARCA4 and thoracic cancer: BRG1 mutation leading to its loss of protein expression or LOF is found in ~10% of cases of NSCLC and is a key diagnostic defect in ~100% of cases of SMARCA4-DTS, a thoracic cancer [4,7,8,44].